• Inavya joins Microsoft Founders Hub. Develops novel GenAI
  • AVATR selected Precision Medicine Startup of the Year 2023
  • AVATR selected Best Startup London 2023
  • Inavya wins an Innovate UK Smart Award. SAVER will create a real-time calculator to improve healthcare efficiency using AVATR.
  • AVATR starts SBRI contract with NHS - AVATR has won a contract for the NHS, to improve patient engagement using Avatr.
  • AVATR in Peru - AVATR was selected to work with the Peru Health Ministry, three hospitals and 300 patients on diabetes management.
  • AVATR showcased at Hospitalar, the largest International Trade Fair for Hospital Equipment & Supplies in Latin America.
  • AVATR featured as a case study by MAP UK & International, specialists in internationalisation and business development.
  • First peer reviewed medical study publication for AVATR in the Journal of Hypertension, demonstrating that AVATR "improves Blood Pressure control and medication adherence".
  • Inavya Ventures (AVATR), The Zerbini Foundation in Brazil, and Hospital das Clínicas in Brazil, announced an innovation partnership, combining their efforts to enrich AVATR-enabled digital healthcare to support patients across Brazil.
  • Inavya Ventures (AVATR) and Acronis announced a technology partnership – combining their efforts to enrich AVATR-enabled digital healthcare services with Acronis’ expert cyber protection, data management and anti-ransomware solutions.
  • Inavya Ventures (AVATR) featured in the Time’s Raconteur report.
  • AVATR’s crowdfunding campaign on Seedrs gets fully funded in 7 minutes.
  • First Cardiac rehab medical study run simultaneously across hospitals in 3 different countries using AVATR (POP90).
  • Imperial College Healthcare NHS Trust - AVATR demonstrator for weight loss management.
  • Barts Hospital NHS - AVATR demonstrator for cardiac rehabilitation.
  • AVATR approved for the UK Government Digital Marketplace.
  • Leeds Teaching Hospitals - patients onboarded for obesity and atrial fib programme.
  • Selected by UK government - healthcare UK Top 100 digital health firms for export.
  • Barclays Eagle Labs Cambridge Judge Business School Accelerator Programme.
  • Frankfurt University Hospital - post-operation monitoring kick-off.
  • InCor HyperTension Medical Study kick off (São Paulo).
  • AVATR selected by the Office for Life Science, to demonstrate cost efficiencies in an NHS setting.
  • AVATR is a CE Marked medical device.
  • Inavya Ventures takes part in the Mayor of London’s TechInvest AI pitch, with a view to expand AVATR’s potential into the Smart Cities arena.
  • The first prototype of AVATR utilising data from the SpyderPro system is brought online.
  • The potential of AVATR to revolutionise healthcare, and doctor/patient relationships is featured in Forbes Magazine.
  • The UK Government’s Department for International Trade selects Inavya Ventures as one of the eleven Tech Superstars to highlight London-based healthcare technology in Singapore.
  • The AVATR Trademark is registered within the EU.
  • With a focus on precision medicine, Inavya Ventures establishes a collaboration agreement with the medical team behind SpyderPro - a medical-grade, wireless ECG monitoring system developed in association with the National Heart Centre Singapore.
  • A Newton Fund R&D grant is awarded to Inavya Ventures to develop and integrate AVATR into a Future Smart Cities project with the city of São Paolo - in partnership with Future Cities Catapult, Space Syntax Ltd., Industrial-I and Brazilian ICT research agency, CPQD.
  • AVATR is certified by the European Commission’s High-Level Expert Group on Key Enabling Technologies as ‘Technology Readiness Level 7’.
  • The product engineering team makes a technical breakthrough with a unique backend prototype (semantic store and related ontologies) that will become the ‘brain’ that powers AVATR.
  • Inavya Ventures Ltd is invited to join a UK Government Trade Mission to Singapore, where AVATR’s AI and Machine Learning technology is featured as a novel innovation with the global healthcare, retail and education markets.
  • As one of the first major signs of UK Government-backed approval, an InnovateUK R&D grant is awarded to Inavya Ventures to support the creation of a ‘quantified self’ technology.
  • AVATR’s parent company Inavya Ventures Limited is born, with a mission to help consumers harness their personal data in conjunction with AI and machine learning.